Quantum-Si Inc (QSI) company profile
Close on Nov 17, 2026Market cap $221.07MP/E –Yield –
About Quantum-Si
Measuring & Controlling Devices, NEC, SIC 3829
Quantum-Si Incorporated is a life sciences company focused on proteomics research and single-molecule protein analysis. The company develops and commercializes next-generation protein sequencing platforms that enable massively parallel protein characterization at single-molecule resolution. Its primary product offerings include the Platinum and Platinum Pro benchtop sequencing instruments, cloud-based and on-instrument Platinum Analysis Software, and specialized consumables such as library preparation, barcoding, and semiconductor sequencing kits. The company serves researchers and clinicians across academic research institutions, biopharmaceutical companies, contract development and manufacturing organizations, government bodies, and industrial laboratories.
The company operates commercially through a direct sales team in the United States and uses a blend of direct sales and distributor arrangements across Europe. In addition, it maintains international distribution partnerships spanning multiple countries throughout the Middle East, Africa, Asia Pacific, and South America, alongside a North American distribution partnership with Avantor. The company is incorporated in Delaware, though its headquarters location is not specified in the text.
Summary of the business section of Quantum-Si's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Quantum-Si Inc
- Founded
- 2013
- Headquarters
- Branford, CT
- Address
- 29 Business Park Drive 06405
- Phone
- (203) 458-7100
- Website
- quantum-si.com
- Employees
- 138, Dec 31, 2025
- Industry
- Measuring & Controlling Devices, NEC
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Deloitte & Touche LLP, New York, New York
Stock & identifiers
- Ticker
- QSI
- Former tickers
- CAPA until Aug 16, 2021
- Exchange
- Nasdaq
- IPO date
- Sep 4, 2020
- Shares outstanding
- 219M, Aug 11, 2026
- Public float
- $286.30M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 41-for-3, May 10, 2022
- SEC CIK
- 1816431
- CUSIP
- 74765K105
- ISIN
- US74765K1051
- FIGI
- BBG00X8RS963
- Share class FIGI
- BBG00X8RS972
- EIN
- 85-1388175
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Jeffrey Alan Hawkins | President & CEO, Director | 3,639,950 |
| Jeffry R. Keyes | Chief Financial Officer | 1,716,684 |
| Christian LaPointe | GC & Corp. Secretary | 1,167,913 |
| John S. Vieceli | Chief Product Officer | 1,140,434 |
| Todd C. Bennett | Chief Commercial Officer | 681,521 |
| Kevin Rakin | Director | 1,220,512 |
| Brigid Makes | Director | 20,512 |
| Amir Jafri | Director | 115,942 |
| Paula Dowdy | Director | 269,107 |
| Charles R. Kummeth | Director | 855,000 |
| John P. Kenny | Director | 114,285 |
| Scott Mendel | Director | 141,843 |
| Ruth A. Fattori | Director | 170,512 |
| Jonathan M. Rothberg | Director | 33,644,178 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $3.18M | -$2.91M | $1.56M | $60 | – |
| FY2024 | $4.44M | $8.72M | $1.65M | $148 | – |
| FY2023 | $1.05M | $1.92M | $1.35M | $110 | – |
| FY2022 Jeffery Hawkins | $7.70M | $6.12M | $2.78M | $23 | – |
| FY2022 John Stark | $816.00K | -$10.09M | $2.78M | $23 | – |
| FY2022 Jonathan Rothberg | $501.67K | -$8.70M | $2.78M | $23 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Jeffrey Hawkins President and Chief Executive Officer | $620.83K | $2.00M | $562.50K | $360 | $3.18M | -28% |
| Jeffry Keyes Chief Financial Officer and Treasurer | $481.67K | $900.00K | $270.63K | $4.55K | $1.66M | -18% |
| John Vieceli Chief Product Officer | $411.67K | $850.00K | $192.98K | $360 | $1.46M | – |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
SPAC offering
- Type
- SPAC (blank check) IPO of units
- Final prospectus filed
- Sep 4, 2020
- Offer price
- $10.00
- Securities offered
- 10,000,000
- Gross proceeds
- $100.00M
- Exchange
- Nasdaq
- Lock-up ends (est.)
- Mar 3, 2021
“Each unit has an offering price of $10.00 and consists of one share of Class A common stock and one-third of one redeemable warrant.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2025 , we employed 138 full-time employees in the United States and 7 full-time employees internationally.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?